Insights into PS exposure mechanisms in cancer cells might facilitate tumor cell specific induction of surface PS, and thus enhance the effectiveness of PS targeting drugs such as SapC-DOPS and anti-PS antibodies [15, 16, 18, 19, 22, 23, 54]. Here, PRB2 is linked to neoplasm.